Coronavirus Disease 2019 (COVID-19) caused by the novel severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has led to considerable morbidity and mortality …

Bat coronavirus RaTG13 shares about 96.2% nucleotide sequence identity with that of
SARS-CoV-2 and uses human and Rhinolophus affinis (Ra) angiotensin-converting enzyme …

Coronaviruses (CoVs) pose a major risk to global public health due to their ability to infect
diverse animal species and potential for emergence in humans. The CoV spike protein …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the agent causing the
global pandemic of COVID-19. SARS-CoV-2 genome encodes a main protease (nsp5, also …

Long COVID-19 syndrome is present in 5–10% of patients infected with SARS-CoV-2, and
there is still little information on the predisposing factors that lead to its development. The …

Introduction Since the outbreak of SARS-CoV-2, vaccines have demonstrated their
effectiveness in resisting virus infection, reducing severity, and lowering the mortality rate in …

Based on the close relationship between dysregulation of redox homeostasis and immune
response in SARS-CoV-2 infection, we proposed a possible modifying role of ACE2 and …

Among the numerous variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-
CoV-2) that have been reported worldwide, the emergence of the Omicron variant has …

Background Global dissemination of SARS-CoV-2 Omicron sublineages has provided a
sufficient opportunity for natural selection, thus enabling beneficial mutations to emerge …

The COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has profoundly
impacted global health, affecting not only the immediate morbidity and mortality rates but …